Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme.

Niswender K, Pi-Sunyer X, Buse J, Jensen KH, Toft AD, Russell-Jones D, Zinman B
Diabetes Obes Metab. 2013 15 (1): 42-54

PMID: 22862847 · DOI:10.1111/j.1463-1326.2012.01673.x

MeSH Terms (22)

Blood Glucose Body Mass Index Diabetes Mellitus, Type 2 Exenatide Female Glucagon-Like Peptide 1 Glycated Hemoglobin A Humans Hypoglycemic Agents Insulin, Long-Acting Insulin Glargine Liraglutide Male Middle Aged Peptides Pyrazines Sitagliptin Phosphate Sulfonylurea Compounds Thiazolidinediones Triazoles Venoms Weight Loss

Connections (1)

This publication is referenced by other Labnodes entities: